Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

The European life science sector remains a key driver of global innovation that is propelled by technological breakthroughs and a robust pipeline of novel therapies. But the European Union (EU) is ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

Delve into Roche's strategy, a company originally built on oncology, now reinventing its pipeline in obesity and immunology.

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

For some biotech companies, a rebrand is the public face of a strategic restructuring after years of pursuing a business model that failed to deliver on its promise. For others, it marks a dramatic ...

For a long time, neurological drug development has largely focused on the cells that ultimately die or malfunction. Alzheimer’s researchers chased amyloid and tau. Parkinson’s drug development ...

A shift in the European pharma sector’s center of gravity might be underway as Spain continues to build on its reputation for innovative biotechnology and life science. Now ranked third in scientific ...

There were several billion-dollar merger and acquisition (M&A) deals last month. The top deal of May was Italian neurology and mental health company Angelini Pharma’s $4.1 billion acquisition of ...